Spread to humans through mosquito bites, Japanese encephalitis (JE) is a rare but potentially serious disease.
Booster doses are now recommended for individuals who remain at ongoing risk of exposure, to be administered 1 to 2 years following the primary course of vaccination. (Boosters are recommended where primary course was with JEspect, or where primary course was administered with Imojev at < 18 years).
MVEC’s JE reference page has been updated with the booster recommendations. The page includes information on JE disease, epidemiology and prevention recommendations.